- Article metrics
- Last updated: Tue, 14 Oct 2025 20:45:42 Z
The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells
Access & Citations
-
- 31k
- Article Accesses
-
- 1111
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
Online attention
- 54 tweeters
- 2 blogs
- 3 Facebook pages
- 6 news outlets
- 583 Mendeley
- 1 Citeulike
This article is in the 96th percentile (ranked 10,075th) of the 332,599 tracked articles of a similar age in all journals and the 69th percentile (ranked 21st) of the 69 tracked articles of a similar age in Nature Medicine
View more on Altmetric
Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Mentions in news and blogs
-
Epigenetic code plays a role in acute myeloid leukemia
Cornell Chronicle -
Epigenetic code plays a role in acute myeloid leukemia
Technology.org -
Epitranscriptomics: The new RNA code and the race to drug it
Chemical & Engineering News -
The prognosis biomarkers based on m6A-related lncRNAs for myeloid leukemia patients
Cancer Cell International -
Epigenetic engineering for oncotherapy
Nature Research Bioengineering Community
This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.